Teva Unveils Plan for Separation of Generic, Specialty Medicine Units

Reorganization of generics business signals CEO Erez Vigodman’s dissatisfaction with the unit’s performance.

comments Print
Teva Pharmaceuticals is introducing a new organizational structure that divides the company’s global operations into generic medicine and specialty medicine units, with the aim of creating a “less complex,...